Free Trial

Arcus Biosciences (RCUS) SEC Filings & 10K Form

$15.72
-0.43 (-2.66%)
(As of 09/6/2024 ET)

Recent Arcus Biosciences SEC Filings

DateFilerForm TypeView
08/27/2024
3:12 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:45 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:53 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:19 PM
Arcus Biosciences (Issuer)
Lambert Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:21 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:28 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
7:18 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
3:59 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
7:21 PM
Arcus Biosciences (Filer)
Form ARS
04/23/2024
3:08 PM
Arcus Biosciences (Filer)
Form DEF 14A
04/23/2024
3:10 PM
Arcus Biosciences (Filer)
Form DEFA14A
03/29/2024
3:20 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
3:19 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:30 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:55 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:55 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:49 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4/A
02/21/2024
3:53 PM
Arcus Biosciences (Filer)
Form S-3ASR
02/21/2024
3:16 PM
Arcus Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
7:35 AM
Arcus Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G
02/07/2024
5:58 PM
Arcus Biosciences (Issuer)
Mercier Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2024
3:58 PM
Arcus Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SC 13D/A
01/31/2024
4:00 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:17 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
6:38 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
6:33 AM
Arcus Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
10:52 AM
Arcus Biosciences (Subject)
Form SC 13G/A
China Stockpiling Gold “Like No Tomorrow” (Ad)

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.
01/04/2024
4:22 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:23 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:44 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:47 PM
Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:17 PM
Arcus Biosciences (Subject)
Jaen Juan C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
3:20 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
3:06 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:28 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
3:35 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:16 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
3:46 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:47 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
3:53 PM
Arcus Biosciences (Subject)
Nuyten Dimitry SA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:49 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:RCUS) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners